In the near future I will introduce a resolution designating May 2025 as Myositis Awareness Month in Pennsylvania.  

Myositis is a rare, autoimmune disease that causes inflammation in the muscles, which can cause prolonged muscle fatigue and weakness. It encompasses several conditions, including juvenile myositis, dermatomyositis and polymyositis, as well as inclusion body myositis. These diseases, sometimes referred to as inflammatory myopathies, can affect the internal organs, skin and multiple muscle groups of patients. 

An estimated 75,000 people in the United States are affected by all forms of Myositis. Treatment for this rare autoimmune disease may include both nondrug and drug-based therapies, including medications such as immunosuppressants or corticosteroids, which slow the body’s immune system and reduce the body’s attack on its muscles, skin and organs. Physical therapy also may be included as a treatment to help improve the patient's physical activity and quality of life. 

Recognizing May as Myositis Awareness Month is an important step in raising awareness and supporting those affected by this rare, yet impactful disease.  

Please join me in co-sponsoring May as Myositis Awareness Month while raising awareness for this